Imiphumela Eceleni ye-Retatrutide: Yini Izivivinyo Zokwelapha Ezisitshela Yona Kuze Kanje

Imiphumela eyenziwa yi-retatrutide evame kakhulu yizinkinga zokugaya ukudla njengokucanuka, uhudo, ukuhlanza, nokuhthiwa. Lokhu kufana nalokho abantu abathola ngakwezinye izidakamizwa ze-GLP-1 njenge-semaglutide ne-tirzepatide. Zivame ukuvela ekuqaleni kokwelashwa, ikakhulukazi lapho kwandiswa umthamo, futhi abantu abaningi bathola ukuthi ziyancipha njengoba umzimba uklama.

I-Retatrutide isengumuthi okusadingeka kuhlale kuwo. Ayikavunyelwa yi-FDA okwamanje futhi isezingweni lwezivivinyo zokwelapha zeSigaba Sesithathu. Ngakho konke esikwaziyo ngemiphumela yayo eyenziwayo kuvela kudatha yezivivinyo. Kodwa-ke, kukhona idatha eningi ebalulekile ongayibheka, okubandakanya imiphumela evela esivivinyweni sakamuva se-TRIUMPH-4 Phase 3.

Yiziphi Izimpawu Eziyivame Kakhulu?

Uhlelo lokugaya ukudla luyathinteka kakhulu, okungenani ekuqaleni. Lokhu kunengqondo ngoba i-retatrutide isebenza ngokuvuselela izindawo ezintathu zamahormone (GLP-1, GIP, ne-glucagon) ezithinta ngqo ukudla, ukuhamba kwamathumbu, nokuthi isisu siyavaleka kanjani ngokushesha.

Esivivinyweni se-Phase 3 TRIUMPH-4, esahlola imithamo emibili ephezulu (9 mg kanye no-12 mg) kubantu abadala abangama-445, imiphumela eyenziwa njalo evame kakhulu kumthamo we-12 mg uma iqhathaniswa ne-placebo yayiyile:

• Ukucanuka (43.2% vs 10.7% ne-placebo)
• Uhudo (33.1% vs 13.4% ne-placebo)
• Ukuhthiwa (25.0% vs 8.7% ne-placebo)
• Ukuhlanza (20.9% vs 0.0% ne-placebo)
• Ukudla okuncishisiwe (18.2% vs 9.4% ne-placebo)

Umthamo we-9 mg ukhombise amazinga aphansi kancane kuwo wonke. Lezi zinombolo ziphakeme kunalokho ojwayele ukukubona nge-semaglutide noma i-tirzepatide, okwenza ukuthi kube sengqondo ngoba i-retatrutide iyisidakamizwa esinamandla kakhulu esisebenza kathathu. Kodwa-ke, ipathen omkhona. Lezi yizinhlobo ezifanayo zemiphumela eyenziwa ngayo eyenzeka nanoma yisiphi isidakamizwa kulesi sigaba.

Into ebalulekile ukwazi ukuthi iningi lalemiphumela eyenziwayo yalinganiswa njengokuncane kuya kokulinganayo. Zazibonakala kakhulu phakathi namaviki okuqala okwelashwa naphakathi kokwanda komthamo, bese ziyathuthuka kancane njengoba abahlanganyeli behlala kumthamo ozinzile.

[IMG:https://assets.getbeyondhealth.com/health-lib/blogs/manual_upload_20260216024926_retatrutide-side-eff.png]

Ingabe i-Retatrutide Iyawuthinta Isivinini Senhliziyo?

Lokhu kuyinto ososayensi abebehlala beqapha kakhulu. Ezivivinyweni zeSigaba Sesibili, abahlanganyeli abathile kumithamo ephezulu babenezinguquko ezincane kwisivinini senhliziyo esingasebenzi, esiphakathi kwezigidi ezi-5 kuye kweziyisikhombisa ngomzuzu. Lokhu kwafinyelela phezulu cishe ngesonto lama-24 bese kancane kancane kubuyela phansi ngamasonto angama-36 kuye kwangama-48.

Inani elincane labahlanganyeli beliphinde laba nezinguquko ezincane zesigqi senhliziyo. Kodwa-ke, akukho ukwanda kwezinhlobo zezinqulu zenhliziyo noma izenzakalo ezinkulu zezinhliziyo eziye zabikwa kunoma yisiphi isivivinyo se-retatrutide kuze kube manje. Eqinisweni, abahlanganyeli bathole ngisho nentuthuko ekucindezelweni kwegazi, i-cholesterol, nezinye izilinganiso zezinhliziyo. Esivivinyweni se-TRIUMPH-4, umthamo we-12 mg wehlise ingcindezi yegazi ye-systolic ngama-mmHg angu-14.

Ngakho-ke, ngenkathi ukwanda okuncane kwesivinini senhliziyo kufanele kuqashwe, isithombe sezinhliziyo zonke sibukeka sinethemba ngokusekelwe kulokho esikwaziyo namuhla.

Yini Isiginali Ye-Dysesthesia?

Lokhu kungumbono omusha ophume emiphumeleni ye-TRIUMPH-4 Phase 3. I-Dysesthesia umuzwa ongajwayelekile noma ongaqabuleki esikhunjeni, ngezinye izikhathi uchazwa njengokubulala, ukuyeka, noma ukushisa. Kubikwe ku-8.8% labahlanganyeli kumthamo we-9 mg kanye no-20.9% kumthamo we-12 mg, uma kuqhathaniswa no-0.7% kuphela nge-placebo.

Le miphumela eyenziwayo ayizange ibonwe ezivivinyweni zeSigaba Sesibili zangaphambilini, ngakho-ke kuyinto entsha abahlaziyi nososayensi abayinaka. U-Eli Lilly wachaza amacala njengokuncane ngokuvamile, futhi ayikaze ibangele abantu ukuthi bayeke ukwelashwa. Kodwa-ke, kusekhona izibuyekezo eziyisikhombisa zezivivinyo ze-Phase 3 ezilindeleke ngo-2026, le nto izobe iqashwa kakhulu ukuze kuqondwe ukuthi ingakanani impela futhi noma iyancipha yini ngokuhamba kwesikhathi.

Ingabe Kukhona Imiphumela Ebalulekile Eceleni?

Izenzakalo ezimbi ezimbi nge-retatrutide ziye zavame kancane ezivivinyweni kuze kube manje. Kodwa-ke, kunezinketho ezimbalwa ezisohlelweni ngoba zibonwe kwezinye izidakamizwa zesigaba se-GLP-1.

Nasi esikubhekayo ososayensi:

• I-Pancreatitis (ukuvuvukala kwe-pancreas) ibikezwe kancane ngezidakamizwa ze-GLP-1 njengesigaba. Akukho cala eliqinisekiswe eliye laboshelwa ngqo ku-retatrutide, kodwa kusengundaba odokotela abaqaphela yona. Izimpawu zokuxwayisa zihlanganisa ubuhlungu obukhulu nobuhlala esiswini obungadlulela emhlane.
• Izinkinga ze-Gallbladder, okubandakanya amatshe e-gallbladder, ziye zazanywa nokulahleka kwesisindo okusheshayo kanye nezinye izidakamizwa ezisekelwe ku-incretin. Izivivinyo ziqaphela lokhu nge-retatrutide futhi.
• I-Hypoglycemia (ukwehla okuyingozi koshukela egazini) kwakungeyona inkinga enkulu ezivivinyweni. Akukho amacala e-hypoglycemia ebucayi abikeziwe, okuyinto ethokozisayo.
• Ukusebenza kwesibindi nezinso kwaqashwa kuwo wonke amathuluzi, futhi akukho zimpawu zokuphepha ezibalulekile eziphume kulezi zindawo.

Kubalulekile ukuphawula ukuthi akukho ukufa okuye kwaboshelwa ku-retatrutide kunoma iyiphi idatha yezivivinyo zokwelapha eyashicilelwe kuze kube manje.

Bangaki Abantu Abayekile Ukwelashwa Ngenxa Yemiphumela Eceleni?

Esivivinyweni se-TRIUMPH-4, amazinga okuyeka ukusebenzisa ngenxa yezingozi ayengu-12.2% kumthamo we-9 mg kanye no-18.2% kumthamo we-12 mg, uma kuqhathaniswa no-4% nge-placebo. Ezinye zalezi zokuyeka zaziyimpela ngenxa yalokho uLilly ayichaza ngokuthi "ukulahleka okweqile okucatshangwayo kwesisindo," hhayi ngenxa yokuzizwa ungaphilile.

Lapho ososayensi bebheka kuphela abahlanganyeli abanomthamo we-BMI ka-35 noma ngaphezulu ekuqaleni (okusho labo abanokukhuluphala okukhudlwana), amazinga okuyeka ancishiswa afinyelela ku-8.8% no-12.1% kumithamo emibili. Lokhu kukhombisa ukuthi abantu abanesisindo sokuqala esiphakeme bangase babekezele isidakamizwa kangcono, mhlawumbe ngoba isivinini sokulahlekelwa kwesisindo sibonakala sibancane kubona.

[IMG:https://assets.getbeyondhealth.com/health-lib/blogs/manual_upload_20260216024317_retatrutide-side.png]

Kungani Ukudlulisela Kancane Kwenza Umehluko?

Izivivinyo ze-Retatrutide zisebenzisa indlela yokudlulisela kancane ngesizathu. Abahlanganyeli baqala kumthamo ophansi we-2 mg bese bekhuphuka njalo emavikini amane kuze kube yini bafinyelela kumthamo wabo ohlosiwe. Lokhu kukhula kancane kunikeza umzimba wakho isikhathi sokuvumelana nezinga ngalinye ngaphambi kokudlulela kokulandelayo.

Le ndlela iyindlela eyodwa ephumelela kakhulu yokunciphisa imiphumela eyenziwayo. Ukugxuma ngqo kumthamo ophezulu kungenza ukucanuka, ukuhlanza, nezinye izimpawu zokugaya ukudla zibe kubi kakhulu. Ukwanda okuncane futhi kungenxa yokuthi abanye abahlanganyeli bathola ukuthi imiphumela yabo yasekuqaleni eyenziwayo iyancipha phakathi namaviki okuqala angama-8 kuye kwayi-12 yokufinyelela kumthamo ozinzile.

Yini Esingakayazi?

Ngoba i-retatrutide iye yahlolwa kuphela kuze kube amasonto angama-68 ezivivinyweni zayo ezide kakhulu, idatha yezokuphepha yesikhathi eside ngaphezu konyaka kusazodingeka. Asikazi ukuthi iphatheni yemiphumela eyenziwayo ibukeka kanjani eminyakeni emibili, emihlanu, noma eyishumi yokusetshenziswa. Imibuzo mayelana nemiphumela engaba khona ekulahlekelweni izinwele, amandla emathambo, isisindo semisipha, nempilo yendlala eshisi ihlala ivulekile kuze kube izivivinyo ezide zinikeza izimpendulo.

U-Eli Lilly unezibuyekezo eziyisikhombisa ezingeziwe ze-Phase 3 ezilindeleke ngo-2026, ezihlanganisa ukukhuluphala, uhlobo 2 lwesifo sikashukela, i-sleep apnea, isifo sesibindi, ubuhlungu obungapheli bemhlane, nemiphumela yezinhliziyo. Lezi zivivinyo zizodweba isithombe esigcwele kakhulu sezinhloso kanye nezingozi.

Uma i-retatrutide ekugcineni ithola imvume ye-FDA, udokotela wakho uzokwazi ukukuhambisa ukuthi ngabe iphatheni yemiphumela eyenziwayo iyazuzisa yini esimweni sakho. Okwamanje, idatha ikhombisa isidakamizwa esinamandla okulahlekelwa kwesisindo nemiphumela eyenziwa yi-manageable kubantu abaningi, ikakhulukazi ngokudlulisela okunakekelayo, okuncane.